Anti-EEF2/Elongation factor 2 antibody [EP880Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(12 Publications)
Rabbit Recombinant Monoclonal EEF2/Elongation factor 2 antibody. Suitable for IHC-P, IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 12 publications.
View Alternative Names
EF2, EEF2, Elongation factor 2, EF-2
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
ab75748 staining EEF2/Elongation factor 2 in HeLa (human cervix adenocarcinoma) cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody at a dilution of 1/100. A goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody. ab7291 and ab150120 were used as counterstains for primary antibody ab75748 and secondary antibody ab150077 respectively and DAPI was used as a nuclear counterstain.
Negative control 1 : Rabbit primary antibody and anti-mouse secondary antibody (ab150120)
Negative control 2 : Mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab150077)
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
Overlay histogram showing HeLa cells stained with ab75748 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab75748, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
ab75748 staining EEF2/Elongation factor 2 in human glioma tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed paraffin-embedded sections). Tissue was fixed with paraformaldehyde and antigen retrieval was by heat mediation in a EDTA buffer. Samples were incubated with primary antibody at a dilution of 1/250. A goat anti-rabbit IgG H&L (HRP) ab97051 was used as the secondary antibody.
Negative control 1 : PBS in place of primary antibody.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
ab75748 stainingEEF2/Elongation factor 2 in the human cell line HEK293 (human embryonic kidney) by intracellular flow cytometry. Cells were fixed with 4% paraformaldehyde and the sample was incubated with the primary antibody at a dilution of 1/70. A goat anti rabbit IgG (Alexa Fluor® 488) at a dilution of 1/500 was used as the secondary antibody.
Isoytype control : Rabbit monoclonal IgG (Black)
Unlabelled control : Cell without incubation with primary antibody and secondary antibody (Blue)
- IP
Unknown
Immunoprecipitation - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
EEF2/Elongation factor 2 was immunoprecipitated using 0.5mg Hela whole cell extract, 5μg of Rabbit monoclonal to EEF2/Elongation factor 2 and 50μl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, Hela whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70oC; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab75748.
Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).
Band : 95kDa; EEF2/Elongation factor 2
All lanes:
Immunoprecipitation - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (ab75748)
Predicted band size: 95 kDa
false
- IP
Lab
Immunoprecipitation - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
ab75748 immunoprecipitating EEF2/Elongation factor 2. 10μg of cell lysate was incubated with primary antibody at a dilution of 1/20 and VeriBlot for IP Detection Reagent (HRP) (ab131366) at a dilution of 1/10000.
Lane 1 : HeLa (human cervix adenocarcinoma) whole cell lysate (10ug)
Lane 2 : HeLa (human cervix adenocarcinoma) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab75748 in HeLa (human cervix adenocarcinoma) whole cell lysate
All lanes:
Immunoprecipitation - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (ab75748)
Predicted band size: 95 kDa
Observed band size: 95 kDa
false
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
ab75748 staining EEF2/Elongation factor 2 in mouse pancreas tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed paraffin-embedded sections). Tissue was fixed with paraformaldehyde and antigen retrieval was by heat mediation in a EDTA buffer. Samples were incubated with primary antibody at a dilution of 1/250. A goat anti-rabbit IgG H&L (HRP) ab97051 was used as the secondary antibody.
Negative control 1 : PBS in place of primary antibody.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
ab75748 staining EEF2/Elongation factor 2 in rat pancreas tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed paraffin-embedded sections). Tissue was fixed with paraformaldehyde and antigen retrieval was by heat mediation in a EDTA buffer. Samples were incubated with primary antibody at a dilution of 1/700. A goat anti-rabbit IgG H&L (HRP) ab97051 was used as the secondary antibody at a dilution of 1/500.
Negative control 1 : PBS in place of primary antibody.
- WB
Unknown
Western blot - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
All lanes:
Western blot - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (ab75748) at 1/50000 dilution
Lane 1:
HEK293 (human embryonic kidney) whole cell lysates at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma) whole cell lysates at 20 µg
Lane 3:
A431 (human epidermoid carcinoma) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 95 kDa
Observed band size: 95 kDa
false
- WB
Lab
Western blot - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (AB75748)
All lanes:
Western blot - Anti-EEF2/Elongation factor 2 antibody [EP880Y] (ab75748) at 1/100000 dilution
Lane 1:
C6 (rat glioma) whole cell lysates at 20 µg
Lane 2:
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysates at 20 µg
Lane 3:
NIH/3T3 (mouse embryo) whole cell lysates at 20 µg
Predicted band size: 95 kDa
false
Related conjugates and formulations (10)
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-EEF2/Elongation factor 2 antibody [EP880Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-EEF2/Elongation factor 2 antibody [EP880Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-EEF2/Elongation factor 2 antibody [EP880Y]
-
Anti-EEF2/Elongation factor 2 antibody [EP880Y] - BSA and Azide free
-
660 APC
APC Anti-EEF2 antibody [EP880Y]
-
HRP Anti-EEF2 antibody [EP880Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-EEF2 antibody [EP880Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-EEF2 antibody [EP880Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-EEF2/Elongation factor 2 antibody [EP880Y]
-
578 PE
PE Anti-EEF2 antibody [EP880Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EEF2 functions as part of a larger ribosomal complex. It has an important role in ensuring the accuracy and efficiency of elongation during the translation process. This process is energy-dependent with EEF2 requiring GTP to catalyze the movement along the mRNA strand. The protein must undergo reversible phosphorylation which directly affects its activity. This post-translational modification of EEF2 is a significant modulation point influencing the rate of protein synthesis.
Pathways
EEF2 plays an integral role in the mTOR signaling pathway and the insulin signaling pathway. In the mTOR pathway EEF2 activity is regulated to control protein translation based on cellular energy status and nutrient availability. This pathway is important for cell growth and proliferation. EEF2 interacts with other proteins such as factor 2 and eEF2kinase which phosphorylates the protein thereby inhibiting its activity. In the insulin signaling pathway similar regulatory mechanisms impact EEF2’s role in translation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Nature cell biology 27:438-448 PubMed39984653
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eadp3680 PubMed39576858
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature 632:656-663 PubMed39048817
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:1753-1763.e7 PubMed38508183
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:104842 PubMed37209825
2023
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 23:e54543 PubMed35993189
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 11:565479 PubMed33250918
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32899302
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:5151 PubMed31723131
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 75:631-643.e8 PubMed31279658
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com